Navigation Links
Westside Medical Imaging Uses High Resolution Magnetic Imaging to Monitor Effects of Cholesterol Drugs on Atherosclerosis
Date:11/9/2011

BEVERLY HILLS, Calif., Nov. 9, 2011 /PRNewswire/ -- Westside Medical Imaging of Beverly Hills announces the availability of High Resolution Magnetic Resonance Imaging with a 3 Tesla magnet to monitor the effects of cholesterol drugs on atherosclerosis.

Drs.Norman Lepor, Hooman Madyoon and Michael Duffy of Westside Medical Associates of Los Angeles (WMALA) have adopted 3 Tesla magnetic resonance imaging (MRI) using specialized vascular coils to monitor how well cholesterol drugs are working by following carotid plaque volume and morphology. According to Dr. Lepor who has reviewed this issue for the upcoming edition of Reviews in Cardiovascular Medicine, "MRI of plaques with a 3 Tesla magnet represents a pivotal development in vascular medicine. It enhances our capability to identify atherosclerotic plaques with a greater degree of sensitivity then carotid intima-media thickness (cIMT) and follow the effects of medical treatments with more accuracy."

Binh Phan, MD, coauthor of this study found that intensive treatment with cholesterol drugs reduced the amount of cholesterol in artery-clogging plaque in 120 patients who were randomly assigned to receive one of three cholesterol treatments: Lipitor; Lipitor plus Niaspan; or Lipitor plus Niaspan and colesevelam. After three years, the volume of cholesterol decreased from 60.4 cubic mm2 to 37.4 mm2, and the percentage of plaque volume consisting of cholesterol decreased from 14.2% to 7.4%.  

According to Dr. Madyoon, "because atherosclerosis occurs in blood vessels throughout the body, plaque buildup in carotid arteries is a good surrogate marker for build up in the coronary arteries indicating a higher risk of heart attack and stroke." Men over the age of 40 years and women as they approach menopause with a history of hypertension, elevated cholesterol, diabetes, smoking history or family history of heart disease should consider this exam.

These findings confirmed the theory that cholesterol medications lead to plaque regression by lowering cholesterol levels. According to Dr. Lepor, "this MRI technology will also allow physicians to individualize cholesterol therapy rather then treat everyone the same." According to Dr. Duffy, "one of the key advantages of this technology is that you can assess the carotid arteries for plaque progression or regression serially over time since it does not expose the patient to any ionizing radiation."

.


'/>"/>
SOURCE Westside Medical Imaging
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical Announces Third Quarter 2011 Results
2. Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs
3. Cantel Medical Corp. to Present at the Stephens Inc. Fall Investment Conference
4. MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation
5. Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
6. BioMarCare Technologies Ltd. Granted Access to Archived Samples in the Hadassah Medical Center
7. Dehaier Medical to Report Third Quarter 2011 Financial Results on November 14
8. Mindray Medical to Exhibit at MEDICA 2011 in Dusseldorf, Germany from November 16-19, 2011
9. Beating Cardiovascular Disease: Continuing Medical Education Course (CME) in Jackson, MS
10. Newly Launched US BioDesign to Provide OEM Development/Manufacturing Services to Medical Device Customers
11. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s ... the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the ... , Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access ...
(Date:3/27/2017)... , ... March 27, 2017 , ... The Case Management ... of Directors on June 30, 2017. CMSA’s membership has elected their upcoming President-Elect, ... our current Military Advisory position, a new VA Advisory position has also been added ...
(Date:3/27/2017)... Birmingham, Clarkston, and Lake Orion, Michigan (PRWEB) , ... ... ... can affect weight loss results. The comprehensive weight management program at Women’s ... begins with an initial evaluation and physical exam. The specialists at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a leading provider of ... row; they are the recipient of the prestigious “Best Overall Design Strategy in ... at Design Connections 2017. Top A&D professionals from leading firms, furniture manufacturers and ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society , ... more than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, ... how to avoid this latter group, tune in to Lifestyle Magazine on ...
Breaking Medicine News(10 mins):